Work

A randomized phase II trial of sipuleucel-T with concurrent or sequential abiraterone acetate (AA) plus prednisone (P) in metastatic castrate-resistant prostate cancer (mCRPC).

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.5047

Authors: Eric Jay Small, Raymond S. Lance, Charles H. Redfern, Frederick E. Millard, Thomas A. Gardner, Lawrence Ivan Karsh, Nancy Ann Dawson, Candice McCoy, Andrew Stubbs, Todd DeVries, Corazon P. dela Rosa, Nadeem A. Sheikh, Neal D. Shore

Institutions: University of California, San Francisco, Eastern Virginia Medical School, University of California San Diego, Moores Cancer Center, Indiana University Health, The Urology Center of Colorado, Georgetown University Medical Center, Dendreon (United States), Carolina Urologic Research Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2601790425

Cites:

Cited by: 26

Related to: 10